Naltrexon Molteni (Naltrexone Hydrochloride)

Naltrexone works by competitively binding to mu, kappa, and delta opioid receptors in the central nervous system. This binding blocks both endogenous and exogenous opioids from activating the receptors, which diminishes the rewarding sensations associated with alcohol and opioid use.

The appropriate dose of Naltrexon Molteni is determined by the prescribing healthcare professional based on the patient’s clinical condition, treatment goals, and response. Dosage regimens may vary, and the prescriber will provide specific instructions.

Safety data for naltrexone in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naltrexone differs from alternatives such as acamprosate (for alcohol) or methadone/buprenorphine (for opioids) by acting as an opioid receptor antagonist rather than a substitute agonist. This mechanism reduces cravings without providing opioid effects, making it suitable for patients seeking abstinence rather than maintenance therapy.

Store Naltrexon Molteni at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Naltrexon Molteni is taken orally, typically as a tablet. The patient should swallow the tablet whole with water, following the dosing schedule prescribed by the healthcare professional.

Serious risks include hepatotoxicity, which may present as elevated liver enzymes or hepatitis, and severe allergic reactions such as anaphylaxis. Additionally, in opioid‑dependent individuals who have not completed detoxification, naltrexone can precipitate acute withdrawal, which requires immediate medical attention.

Naltrexon Molteni should be avoided in patients with active liver disease, acute hepatitis, or those currently dependent on opioids who have not undergone proper detoxification, as it can trigger severe withdrawal. It is also contraindicated in individuals with known hypersensitivity to naltrexone.